• LAST PRICE
    1.1900
  • TODAY'S CHANGE (%)
    Trending Down-0.0600 (-4.8000%)
  • Bid / Lots
    1.1900/ 6
  • Ask / Lots
    1.3100/ 9
  • Open / Previous Close
    1.2500 / 1.2500
  • Day Range
    Low 1.1900
    High 1.2500
  • 52 Week Range
    Low 0.4126
    High 1.9280
  • Volume
    1,187,883
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.25
TimeVolumeNKTR
09:32 ET250601.24
09:34 ET52501.25
09:36 ET17011.25
09:38 ET9001.248
09:39 ET45111.2495
09:41 ET3001.248
09:43 ET42881.245
09:45 ET3001.25
09:48 ET6001.245
09:50 ET5001.245
09:52 ET190561.2201
09:54 ET385221.225
09:56 ET182251.215
09:57 ET137801.219
09:59 ET30811.215
10:01 ET9881.215
10:03 ET50721.22
10:06 ET399421.24
10:08 ET337691.235
10:10 ET320691.23
10:12 ET25071.225
10:14 ET22941.225
10:17 ET49001.2217
10:21 ET1001.23
10:26 ET6001.225
10:28 ET9871.225
10:30 ET116761.235
10:32 ET31431.235
10:33 ET88481.235
10:35 ET3001.23
10:37 ET158611.225
10:39 ET3711.225
10:42 ET121471.225
10:44 ET1001.225
10:46 ET1001.225
10:48 ET3001.22
10:50 ET93911.215
10:51 ET1001.215
10:55 ET1001.215
10:57 ET1001.215
11:00 ET2001.21
11:02 ET8001.215
11:04 ET25181.21
11:06 ET2001.21
11:09 ET1001.215
11:15 ET4001.21
11:18 ET1001.2146
11:20 ET2001.215
11:22 ET10151.215
11:24 ET133471.215
11:26 ET226161.225
11:27 ET17001.22
11:29 ET163841.218
11:33 ET1001.215
11:36 ET4001.215
11:40 ET3021.22
11:42 ET11381.215
11:45 ET2401.215
11:47 ET22581.215
11:54 ET17001.22
11:58 ET2001.215
12:00 ET3001.22
12:02 ET5341.215
12:12 ET2001.215
12:16 ET2001.215
12:18 ET16971.215
12:23 ET138651.215
12:25 ET7001.215
12:27 ET8001.215
12:30 ET10001.22
12:32 ET1001.22
12:34 ET6301.215
12:36 ET1501.21
12:38 ET1001.215
12:39 ET1001.215
12:41 ET163401.215
12:43 ET4001.215
12:45 ET3001.22
12:48 ET1001.22
12:50 ET7651.215
12:52 ET313331.205
12:54 ET10001.205
12:56 ET1001.205
12:57 ET5531.2
12:59 ET5001.2
01:01 ET16001.2
01:03 ET26321.2
01:06 ET61841.205
01:08 ET54021.21
01:10 ET4001.2089
01:12 ET5531.2004
01:14 ET2001.205
01:15 ET1001.205
01:17 ET2581.2
01:24 ET1001.205
01:26 ET1001.205
01:30 ET1001.205
01:32 ET5891.209
01:33 ET6131.2099
01:35 ET2001.205
01:39 ET43001.205
01:42 ET5391.205
01:44 ET65921.21
01:46 ET2831.2057
01:48 ET13901.205
01:51 ET1001.205
01:53 ET1871.205
01:57 ET3001.2056
02:00 ET2001.205
02:04 ET7221.205
02:08 ET2001.21
02:09 ET6751.21
02:11 ET1931.205
02:15 ET6001.21
02:18 ET2001.205
02:20 ET1001.205
02:22 ET15211.205
02:24 ET247351.21
02:26 ET9081.206
02:27 ET50091.21
02:29 ET18301.21
02:31 ET104861.22
02:33 ET11501.215
02:36 ET205951.205
02:38 ET2651.21
02:40 ET7001.205
02:42 ET18001.205
02:45 ET19001.205
02:47 ET4001.205
02:49 ET7001.21
02:54 ET9001.21
02:56 ET9001.21
02:58 ET23321.205
03:00 ET4001.205
03:02 ET12981.205
03:03 ET114311.21
03:05 ET10001.21
03:07 ET10001.21
03:09 ET8001.21
03:12 ET4001.21
03:14 ET33041.21
03:16 ET7931.21
03:18 ET16001.21
03:20 ET22001.21
03:21 ET13601.21
03:23 ET20001.21
03:25 ET39051.208
03:27 ET16351.21
03:30 ET13001.21
03:32 ET31221.21
03:34 ET13001.21
03:36 ET15001.21
03:38 ET20441.21
03:39 ET44161.21
03:41 ET30671.21
03:43 ET152701.205
03:45 ET119441.215
03:48 ET42671.215
03:50 ET571821.215
03:52 ET57101.22
03:54 ET60421.22
03:56 ET102061.215
03:57 ET2310051.195
03:59 ET1482371.19
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNKTR
Nektar Therapeutics
230.1M
-1.3x
---
United StatesTSVT
2Seventy Bio Inc
235.9M
-1.4x
---
United StatesENTA
Enanta Pharmaceuticals Inc
243.5M
-2.1x
---
United StatesCDXC
Chromadex Corp
271.8M
-193.9x
---
United StatesEDIT
Editas Medicine Inc
249.1M
-1.2x
---
United StatesCDXS
Codexis Inc
227.7M
-2.9x
---
As of 2024-10-31

Company Information

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company. The Company is focused on discovering and developing medicines in the field of immunotherapy. The Company has a research and development pipeline of investigational medicines in immunology and oncology. In oncology, it is focused on developing medicines based on targeting biological pathways that stimulate and sustain the body’s immune response to fight cancer. Its pipeline includes NKTR-255, Rezpegaldesleukin (REZPEG) and NKTR-0165. NKTR-255 is an investigational biologic that is designed to target the interleukin-15 (IL-15) pathway in order to activate the body’s innate and adaptive immunity. Its Rezpegaldesleukin pipeline is an investigational, potential first-in-class T regulatory cell stimulator that addresses this underlying immune system imbalance in people with many autoimmune and inflammatory conditions. Rezpegaldesleukin is being developed as a self-administered injection.

Contact Information

Headquarters
455 Mission Bay Boulevard SouthSAN FRANCISCO, CA, United States 94158
Phone
415-482-5300
Fax
415-339-5300

Executives

Independent Chairman of the Board
Robert Chess
President, Chief Executive Officer
Howard Robin
Interim Chief Financial Officer
Sandra Gardiner
Senior Vice President, Chief Legal Officer
Mark Wilson
Chief Research and Development Officer
Jonathan Zalevsky

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$230.1M
Revenue (TTM)
$93.2M
Shares Outstanding
184.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.60
EPS
$-0.90
Book Value
$0.68
P/E Ratio
-1.3x
Price/Sales (TTM)
2.5
Price/Cash Flow (TTM)
---
Operating Margin
-175.59%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.